Distinct outcome patterns according to RAS and BRAF status in MSI-H/dMMR mCRC treated with immune checkpoint inhibitors: A systematic review and meta-analysis.
Saved in:
| Title: | Distinct outcome patterns according to RAS and BRAF status in MSI-H/dMMR mCRC treated with immune checkpoint inhibitors: A systematic review and meta-analysis. |
|---|---|
| Authors: | Pretta A; Medical Oncology Unit, University Hospital and University of Cagliari, Italy. Electronic address: an.pretta@gmail.com., Giampieri R; Clinica Oncologica - Dipartimento Scienze Cliniche e Molecolari - Università Politecnica delle Marche, Italy; Azienda Ospedaliero Universitaria delle Marche -Ancona, Italy., Bottelli A; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Taravella A; Unit of Oncology, University Hospital of Pisa, Italy; Department of Translational Research & New Technologies in Medicine & Surgery, University of Pisa, Italy., Intini R; Oncology Unit 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy., Ziranu P; Medical Oncology Unit, University Hospital and University of Cagliari, Italy., Liguori C; Clinica Oncologica - Dipartimento Scienze Cliniche e Molecolari - Università Politecnica delle Marche, Italy; Azienda Ospedaliero Universitaria delle Marche -Ancona, Italy., Manoni F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Landi M; Unit of Oncology, University Hospital of Pisa, Italy; Department of Translational Research & New Technologies in Medicine & Surgery, University of Pisa, Italy., Maddalena G; Oncology Unit 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy., Locci G; Unit Of Anatomic Pathology, ARNAS G.Brotzu of Cagliari, Italy., Donisi C; Medical Oncology Unit, University Hospital and University of Cagliari, Italy., Masiello M; Clinica Oncologica - Dipartimento Scienze Cliniche e Molecolari - Università Politecnica delle Marche, Italy; Azienda Ospedaliero Universitaria delle Marche -Ancona, Italy., Caschili M; Medical Oncology Unit, University Hospital and University of Cagliari, Italy., Bassetti A; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Pasquinucci V; Unit of Oncology, University Hospital of Pisa, Italy; Department of Translational Research & New Technologies in Medicine & Surgery, University of Pisa, Italy., Maccioni A; Medical Oncology Unit, University Hospital and University of Cagliari, Italy., Sperotto S; Oncology Unit 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy., Bergamo F; Oncology Unit 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy., Berardi R; Clinica Oncologica - Dipartimento Scienze Cliniche e Molecolari - Università Politecnica delle Marche, Italy; Azienda Ospedaliero Universitaria delle Marche -Ancona, Italy., Pietrantonio F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Cremolini C; Unit of Oncology, University Hospital of Pisa, Italy; Department of Translational Research & New Technologies in Medicine & Surgery, University of Pisa, Italy., Lonardi S; Oncology Unit 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy., Scartozzi M; Medical Oncology Unit, University Hospital and University of Cagliari, Italy. |
| Source: | Cancer treatment reviews [Cancer Treat Rev] 2026 Jun 25; Vol. 149, pp. 103178. Date of Electronic Publication: 2026 Jun 25. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7502030 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1967 (Electronic) Linking ISSN: 03057372 NLM ISO Abbreviation: Cancer Treat Rev Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
